GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kadimastem Ltd (XTAE:KDST) » Definitions » Common Stock

Kadimastem (XTAE:KDST) Common Stock : ₪4.19 Mil (As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Kadimastem Common Stock?

Kadimastem's quarterly common stock increased from Dec. 2022 (₪3.64 Mil) to Jun. 2023 (₪4.19 Mil) but then stayed the same from Jun. 2023 (₪4.19 Mil) to Dec. 2023 (₪4.19 Mil).

Kadimastem's annual common stock increased from Dec. 2021 (₪3.37 Mil) to Dec. 2022 (₪3.64 Mil) and increased from Dec. 2022 (₪3.64 Mil) to Dec. 2023 (₪4.19 Mil).


Kadimastem Common Stock Historical Data

The historical data trend for Kadimastem's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kadimastem Common Stock Chart

Kadimastem Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.03 1.94 3.37 3.64 4.19

Kadimastem Semi-Annual Data
Dec13 Dec14 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.37 3.49 3.64 4.19 4.19

Kadimastem Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Kadimastem (XTAE:KDST) Business Description

Traded in Other Exchanges
Address
Pinchas Sapir 7, Weizmann Science Park, Nes-Ziona, ISR
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.

Kadimastem (XTAE:KDST) Headlines

No Headlines